Search results for "Candida sp"
showing 10 items of 26 documents
Untargeted Antifungal Treatment in Nonneutropenic Critically Ill Patients: Should Further Studies Be Performed Based on Trial Sequential Analysis Res…
2018
Should we continue to use prediction tools to identify patients at risk of Candida spp. infection? If yes, why?
2016
Background Given the predominance of invasive fungal disease (IFD) amongst the non-immunocompromised adult critically ill population, the potential benefit of antifungal prophylaxis and the lack of generalisable tools to identify high risk patients, the aim of the current study was to describe the epidemiology of IFD in UK critical care units, and to develop and validate a clinical risk prediction tool to identify non-neutropenic, critically ill adult patients at high risk of IFD who would benefit from antifungal prophylaxis. Methods Data on risk factors for, and outcomes from, IFD were collected for consecutive admissions to adult, general critical care units in the UK participating in the…
Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units.
2016
BACKGROUND: Given the predominance of invasive fungal disease (IFD) amongst the non-immunocompromised adult critically ill population, the potential benefit of antifungal prophylaxis and the lack of generalisable tools to identify high risk patients, the aim of the current study was to describe the epidemiology of IFD in UK critical care units, and to develop and validate a clinical risk prediction tool to identify non-neutropenic, critically ill adult patients at high risk of IFD who would benefit from antifungal prophylaxis. METHODS: Data on risk factors for, and outcomes from, IFD were collected for consecutive admissions to adult, general critical care units in the UK participating in t…
Evaluation of a novel chromogenic medium for Candida spp. identification and comparison with CHROMagar™ Candida for the detection of Candida auris in…
2020
Abstract A shift to Candida non-albicans infections has been noted during the last years, and the emergence of multi-resistant Candida auris has complicated their management. The aim of this study was first to compare the performance of the novel chromogenic medium CHROMagar™ Candida Plus (CHROMagar, France) with CHROMagar™ Candida (Becton Dickinson, Germany) for the presumptive identification of Candida species; and then, to evaluate its utility in the detection of C. auris in surveillance samples. CHROMagar™ Candida Plus showed a good performance compared with the reference medium CHROMagar™ Candida. Sensitivity and specificity were 100% in both media for tested species at 48 h of incubat…
Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris
2018
Abstract Candida spp. infections are a major cause of morbidity and mortality in critically ill patients. Candida auris is an emerging multi-drug-resistant fungus that is rapidly spreading worldwide. Since the first reports in 2009, many isolates across five continents have been identified as agents of hospital-associated infections. Independent and simultaneous outbreaks of C. auris are becoming a major concern for healthcare and scientific community. Moreover, laboratory misidentification and multi-drug-resistant profiles, rarely observed for other non-albicans Candida species, result in difficult eradication and frequent therapeutic failures of C. auris infections. The aim of this review…
Chemical and antifungal investigations of six Lippia species (Verbenaceae) from Brazil
2012
Made available in DSpace on 2013-09-27T14:52:47Z (GMT). No. of bitstreams: 1 WOS000310396700165.pdf: 536437 bytes, checksum: d267984ddfcb57d1406b069856adcc25 (MD5) Previous issue date: 2012-12-01 Made available in DSpace on 2013-09-30T19:10:31Z (GMT). No. of bitstreams: 1 WOS000310396700165.pdf: 536437 bytes, checksum: d267984ddfcb57d1406b069856adcc25 (MD5) Previous issue date: 2012-12-01 Submitted by Vitor Silverio Rodrigues (vitorsrodrigues@reitoria.unesp.br) on 2014-05-20T14:20:39Z No. of bitstreams: 1 WOS000310396700165.pdf: 536437 bytes, checksum: d267984ddfcb57d1406b069856adcc25 (MD5) Made available in DSpace on 2014-05-20T14:20:39Z (GMT). No. of bitstreams: 1 WOS000310396700165.pdf: …
What Is the Most Recent Evidence on the Prevention and Early Treatment of Invasive Fungal Infections in Nonneutropenic Critically Ill Patients?
2017
: Invasive fungal infections (IFIs) are associated with high morbidity and mortality in intensive care units. Candida species are the most important fungal pathogens and among the most frequent causes of infection in critically ill patients. Studies have evaluated the correlation between the onset of antifungal treatment and survival. However, definitive diagnosis of IFI is time-consuming in clinical practice. Antifungal prophylaxis and preemptive or empirical treatments are among therapeutic strategies to prevent or treat early fungal infections in selected patients. Recently, new evidence from randomized controlled trials and systematic reviews has been published. Moreover, new clinical p…
Candida ģints sēņu jutības pret antifungālajiem līdzekļiem noteikšana
2015
Bakalaura darbs tika izstrādāts LU Medicīnas fakultātē Mg. Sc. biol. Ivetas Līdumas vadībā. Bakalaura darbā ir analizēta Mikobakterioloģiskajā laboratorijā identificēto no klīniskajiem paraugiem izdalīto raugveida sēņu dati, ka arī pētīta sēņu paraugu jutība, pret antifungālajiem līdzekļiem (amfotericīnu B, itrakonazolu, flukonazolu). Sēņu sugas tika identificētas izmantojot mikroskopisko analīzi, ka arī veicot uzsējumus uz BBL™ CHROMagar™ barotnes. Lai noteiktu antifungālo jutību tika izmantota standartizēta disku difūzijas metode, izmantojot CLSI noteiktos kritērijus, kā arī lietojot E-testus tika noteikta MIC (minimālā inhibējošā koncentrācija). Jutība pret antifungālajiem līdzekļiem tik…
Being candid about Candida airway colonization and clinical outcomes: What can we really learn from unadjusted associations?
2020
Global warming “heating up” the ICU through Candida auris infections: the climate changes theory
2019
The most enigmatic aspect of the rise of Candida auris as a human pathogen is that it emerged simultaneously on three continents, with each clade being genetically distinct. Although new pathogenic fungal species are described regularly, these are mostly species associated with single cases in individuals who are immunosuppressed.